Elequin Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-33
Closed -$1.44K 601
2024
Q3
$1.44K Buy
+33
New +$1.24K ﹤0.01% 328
2024
Q2
Sell
-13
Closed -$380 302
2024
Q1
$380 Buy
+13
New +$394 ﹤0.01% 210
2023
Q3
Sell
-130
Closed -$9.58K 552
2023
Q2
$9.58K Buy
+130
New +$8.77K ﹤0.01% 306
2022
Q4
Sell
-126
Closed -$11K 697
2022
Q3
$11K Sell
126
-126
-50% -$13.2K ﹤0.01% 236
2022
Q2
$29K Buy
252
+17
+7% +$1.95K 0.01% 173
2022
Q1
$30K Buy
+235
New +$33.9K 0.01% 92

Other funds holding OMCL

Elequin Capital's OMCL Position: Q4 2024 in Review

Elequin Capital sold out of Omnicell (OMCL) in Q4 2024, closing a stake of 33 shares — an estimated $1.44K sold.

Elequin Capital first reported a position in OMCL in Q1 2022 and held it in 6 quarters. The position peaked at $30K in Q1 2022. 279 funds tracked by Wall St. Rank hold OMCL as of Q4 2024.

  • Elequin Capital reported no remaining Omnicell position as of Q4 2024 after selling out during the quarter.
  • Elequin Capital sold 33 Omnicell shares in Q4 2024, an estimated $1.44K.
  • Elequin Capital first reported a position in Omnicell in Q1 2022 and held it in 6 quarters.
  • Elequin Capital's Omnicell position peaked at $30K in Q1 2022.
  • 279 funds tracked by Wall St. Rank held Omnicell as of Q4 2024.

Based on Elequin Capital's 13F filing for Q4 2024, filed 18 Feb 2025.